Now, this won't come as too much of a surprise to Eli Lilly and its peers. A few weeks ago, the company's CEO, David Ricks, ...

We recently published a list of the Best Income Stocks to Invest in Now. In this article, we are going to take a look at ...

We came across a bullish thesis on Eli Lilly and Company (LLY) on Substack by Kontra. In this article, we will summarize the bulls’ thesis on LLY. Eli Lilly and Company (LLY)'s share was trading ...

To watch more expert insights and analysis on the latest market action, check out more Catalysts here. Even though Eli Lilly and Company ( NYSE:LLY ) posted strong earnings, investors appeared to ...

INDIANAPOLIS, May 5, 2025 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE:LLY) has declared a dividend for the second quarter of 2025 of $1.50 per share on outstanding common ...

Eli Lilly ( LLY 2.92%) and Novo Nordisk ( NVO -0.89%) were early leaders in the development of GLP-1 agonists, and dominate the market. Research from MarketsandMarkets suggests that annual global ...

shares plunge Eli Lilly on Thursday downplayed CVS Health's decision to drop the company's obesity drug Zepbound from some lists of medicines it covers for reimbursement, but shares of the ...

We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential.

LEBANON, Ind. — Eli Lilly and Company wants to be able to produce the supply of all its medicines Americans need right here in the United States. Much of that medicine will be produced at a ...

"If approved, the company ... at Weill Cornell Medicine, calls the new drug "transformational." Aronne has been treating obesity for 35 years and is a consultant for Eli Lilly.

We came across a bullish thesis on Eli Lilly and Company (LLY) on Substack by Kontra. In this article, we will summarize the bulls’ thesis on LLY. Eli Lilly and Company (LLY)'s share was trading at ...